1-10 of 10
Maurizio Frezzato
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Obinutuzumab in Relapsed or Refractory Hairy Cell Leukemia (R/R HCL): An Italian Multicenter Phase-2 Academic Trial (HCL-PG04)

Enrico Tiacci, Luca De Carolis, Monia Capponi, Flavio Falcinelli, Francesco Zaja, Alessandro Pulsoni, Edoardo Simonetti, Elisa Montechiarello, Alessandra Romano, Jacopo Olivieri, Alessandro Mancini, Gianna Maria D'Elia, Robin Foa, Maurizio Frezzato, Brunangelo Falini
Journal: Blood
Blood (2023) 142 (Supplement 1): 4398.
https://doi.org/10.1182/blood-2023-180035
Published: 2023
Journal Articles

Sequential Matrix-RICE Therapy Followed By Autologous Stem Cell Transplant in Patients with Diffuse Large B-Cell Lymphoma and Secondary Central Nervous System Involvement: The International Extranodal Lymphoma Study Group-42 Phase II (MARIETTA) Trial

Andres JM Ferreri, MD, Jeanette K. Doorduijn, MD PhD, Chiara Cattaneo, MD, Maria Giuseppina Cabras, MD, Jeffery Smith, MBChB BMedSci MRCP FRCPath, Fiorella Ilariucci, Franco Narni, Teresa Calimeri, MD PhD, Alessandro Re, MD, Jahanzaib Khwaja, Barbara Botto, Claudia Cellini, MD, Luca Nassi, Kim Linton, MBChB PhD, Pam McKay, MD, Jacopo Olivieri, Caterina Patti, MD, Francesca Re, Alessandro Fanni, MD, Vikram Singh, MD, Jacoline Bromberg, MD, Kelly Cozens, Elisabetta Gastaldi, Nicola Cascavilla, Andrew Davies, MD PhD, Christopher P Fox, MBChB(Hons), MRCP, FRCPath, PhD, Maurizio Frezzato, MD, Wendy Osborne, MBBS, Anna Marina Liberati, Urban Novak, Renato Zambello, Emanuele Zucca, MD, Kate Cwynarski, PhDMD
Journal: Blood
Blood (2019) 134 (Supplement_1): 353.
https://doi.org/10.1182/blood-2019-129835
Published: 2019
Journal Articles

Multicenter Phase II Trial Addressing Lenalidomide Maintenance in Patients with Relapsed Diffuse Large B-Cell Lymphoma (rDLBCL) Who Are Not Eligible for Autologous Stem Cell Transplantation (ASCT): Efficacy and Safety Results after a Median Follow-up of Five Years

Andres JM Ferreri, MD, Marianna Sassone, MD, Francesco Zaja, MD, Alessandro Re, MD, Michele Spina, MD, Alice Di Rocco, Alberto Fabbri, MD, Piera Angelillo, MD, Caterina Stelitano, MD, Maurizio Frezzato, MD, Chiara Rusconi, Renato Zambello, MD, Annalisa Arcari, MD, Giovanni Bertoldero, MD, Daniela De Lorenzo, BD, Eloise Scarano, Stefano Volpetti, MD, Salvatore Perrone, MD, Teresa Calimeri, MDPhD, Caterina Cecchetti, MD, Fabio Ciceri, MD, Maurilio Ponzoni, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1688.
https://doi.org/10.1182/blood-2018-99-116060
Published: 2018
Journal Articles

Lenalidomide Maintenance Significantly Improves Survival Figures in Patients with Relapsed Diffuse Large B-Cell Lymphoma (rDLBCL) Who Are Not Eligible for Autologous Stem Cell Transplantation (ASCT): Final Results of a Multicentre Phase II Trial

Andrés J.M. Ferreri, MD, Marianna Sassone, MD, Francesco Zaja, MD, Alessandro Re, MD, Michele Spina, Alice Di Rocco, MD, Alberto Fabbri, MD, Caterina Stelitano, MD, Maurizio Frezzato, MD, Chiara Rusconi, MD, Renato Zambello, MD, Suzana Couto, MD, Yan Ren, MD, Annalisa Arcari, Giovanni Bertoldero, MD, Lucilla Tedeschi, MD, Francesca Re, MD, Lydia Scarfo, Teresa Calimeri, MD PhD, Caterina Cecchetti, MD, Marianna Chiozzotto, MD, Silvia Govi, MD, Maurilio Ponzoni, MD
Journal: Blood
Blood (2016) 128 (22): 474.
https://doi.org/10.1182/blood.V128.22.474.474
Published: 2016
Journal Articles

Lenalidomide Maintenance Significantly Improves Progression-Free Survival (PFS) in Patients with Chemosensitive Relapse of Diffuse Large B-Cell Lymphoma (DLBCL) Who Are Not Eligible for Autologous Stem Cell Transplantation (ASCT) or Experienced Relapse after Transplantation: Results of a Multicentre Phase II Trial

Andrés J.M. Ferreri, Marianna Sassone, Marianna Chiozzotto, Michele Spina, MD, Alessandra Tucci, Alice Di Rocco, Alberto Fabbri, Caterina Stelitano, Maurizio Frezzato, Renato Zambello, Giovanni Bertoldero, Chiara Rusconi, MD, Annalisa Arcari, Lydia Scarfo, Silvia Govi, Maurilio Ponzoni, MD, Francesco Zaja, MD
Journal: Blood
Blood (2015) 126 (23): 1547.
https://doi.org/10.1182/blood.V126.23.1547.1547
Published: 2015
Journal Articles

Chemoimmunotherapy with R-CHOP or High Dose Sequential Therapy with Autologous Stem Cell Transplantation (R-HDS) for High Risk Diffuse Large B-Cell Lymphomas Patients: Results of the Randomized R-HDS0305 Trial by Gruppo Italiano Terapie Innovative Nei Linfomi (GITIL)

Sergio Cortelazzo, MD, Corrado Tarella, MD, Alessandro Massimo Gianni, MD, Tiziano Barbui, MD, Marco Ladetto, MD, Anna Maria Barbui, MD, Andrea Rossi, MD, Paolo Corradini, MD, Massimo Di Nicola, MD, Caterina Patti, MD, Antonino Mulé, MD, Manuela Zanni, MD, Valerio Zoli, MD, Atto Billio, MD, Andrea Gallamini, MD, Francesco Di Raimondo, MD, Andrés J.M. Ferreri, MD, Giovanni Pizzolo, MD, Giorgio La Nasa, MD, Pietro Leoni, MD, Giampietro Semenzato, MD, Maurizio Frezzato, MD, Leonardo Flenghi, MD, Marco Scarano, Sc.D., Arianna Masciulli, BSc, Roberto Marchioli, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2012) 120 (21): 746.
https://doi.org/10.1182/blood.V120.21.746.746
Published: 2012
Journal Articles

Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-Dose Cytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis

Andres JM Ferreri, MD, Michele Reni, M.D., Marco Foppoli, M.D., Maurizio Martelli, M.D., Marina Siakantaris, M.D., Maurizio Frezzato, M.D., Maria Giuseppina Cabras, M.D., Alberto Fabbri, M.D., Gaetano Corazzelli, M.D., Fiorella Ilariucci, M.D., Giuseppe Rossi, M.D., Riccardo Soffietti, M.D., Caterina Stelitano, M.D., Daniele Vallisa, M.D., Francesco Zaja, M.D., Marta Gelemur, M.D., Gian Marco Aondio, M.D., Giuseppe Avvisati, M.D., Monica Balzarotti, MD, Alba Brandes, M.D., Maria Joao Costa, MD, Henry Gomez, M.D., Attilio Guarini, M.D., Graziella Pinotti, M.D., Luigi Rigacci, M.D., Catrina Uhlmann, M.D., Maria Angelopoulou, M.D., Maria Tirindelli, M.D., Virginia Naso, M.D., Alberto Franzin, M.D., Nicoletta Anzalone, M.D., Maurilio Ponzoni, M.D., Emanuele Zucca, M.D., Federico Caligaris- Cappio, M.D., Franco Cavalli, M.D.
Journal: Blood
Blood (2008) 112 (11): 580.
https://doi.org/10.1182/blood.V112.11.580.580
Published: 2008
Journal Articles

Splenic marginal zone lymphoma: a prognostic model for clinical use

Clinical Trials & Observations
Luca Arcaini, Mario Lazzarino, Nora Colombo, Sara Burcheri, Emanuela Boveri, Marco Paulli, Enrica Morra, Marcello Gambacorta, Sergio Cortelazzo, Alessandra Tucci, Marco Ungari, Achille Ambrosetti, Fabio Menestrina, Lorella Orsucci, Domenico Novero, Alessandro Pulsoni, Maurizio Frezzato, Gianluca Gaidano, Daniele Vallisa, Viviana Minardi, Claudio Tripodo, Vincenzo Callea, Luca Baldini, Francesco Merli, Massimo Federico, Vito Franco, Emilio Iannitto, for the Intergruppo Italiano Linfomi
Journal: Blood
Blood (2006) 107 (12): 4643–4649.
https://doi.org/10.1182/blood-2005-11-4659
Published: 2006
Journal Articles

HCV Infection in Nongastric Marginal Zone B-Cell Lymphoma of MALT.

Luca Arcaini, Sara Burcheri, Andrea Rossi, Francesco Passamonti, Nora Colombo, Marco Paulli, Emanuela Boveri, Ercole Brusamolino, Alfredo Molteni, Alessandro Pulsoni, Maria Christina Cox, Lorella Orsucci, Alberto Fabbri, Maurizio Frezzato, Maria Teresa Voso, Francesco Zaja, Cristiana Pascutto, Enrica Morra, Sergio Cortelazzo, Mario Lazzarino
Journal: Blood
Blood (2005) 106 (11): 987.
https://doi.org/10.1182/blood.V106.11.987.987
Published: 2005
Journal Articles

The Incidence of Chronic Lymphocytic Leukemia in the General Population.

Maurizio Frezzato, Alberto Tosetto, Ilaria Giaretta, Francesco Rodeghiero
Journal: Blood
Blood (2004) 104 (11): 2809.
https://doi.org/10.1182/blood.V104.11.2809.2809
Published: 2004